Similar articles for PMID: 16735672

Year	Number of Results
1965	1
1978	1
1981	1
1982	2
1989	3
1990	2
1991	1
1992	2
1993	3
1994	2
1995	3
1996	3
1997	2
1998	5
1999	10
2000	11
2001	15
2002	14
2003	19
2004	27
2005	23
2006	20
2007	19
2008	23
2009	15
2010	18
2011	10
2012	10
2013	5
2014	3
2015	6
2016	7
2017	4
2018	4
2019	2
2020	4
2021	2
2022	2
2023	2
2024	0

1

Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.

McAlister FA, Ghali WA, Gong Y, Fang J, Armstrong PW, Tu JV. McAlister FA, et al. Circulation. 2006 Jun 6;113(22):2572-8. doi: 10.1161/CIRCULATIONAHA.105.602136. Epub 2006 May 30. Circulation. 2006. PMID: 16735672

2

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.

Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML; APPROACH Investigators. Ezekowitz J, et al. J Am Coll Cardiol. 2004 Oct 19;44(8):1587-92. doi: 10.1016/j.jacc.2004.06.072. J Am Coll Cardiol. 2004. PMID: 15489090 Free article.

3

Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN. Anand IS, et al. Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5. Circulation. 2009. PMID: 19805651 Clinical Trial.

4

Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes.

Masoudi FA, Wolfe P, Havranek EP, Rathore SS, Foody JM, Krumholz HM. Masoudi FA, et al. J Am Coll Cardiol. 2005 Sep 20;46(6):955-62. doi: 10.1016/j.jacc.2004.07.062. J Am Coll Cardiol. 2005. PMID: 16168275 Free article.

5

Renal insufficiency as an independent predictor of mortality among women with heart failure.

Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Grady D, Shlipak MG. Bibbins-Domingo K, et al. J Am Coll Cardiol. 2004 Oct 19;44(8):1593-600. doi: 10.1016/j.jacc.2004.07.040. J Am Coll Cardiol. 2004. PMID: 15489091 Free article. Clinical Trial.

6

Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure: a dose-related adverse effect of aspirin.

Guazzi M, Brambilla R, Reina G, Tumminello G, Guazzi MD. Guazzi M, et al. Arch Intern Med. 2003 Jul 14;163(13):1574-9. doi: 10.1001/archinte.163.13.1574. Arch Intern Med. 2003. PMID: 12860580

7

Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.

Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W. Pietrasik G, et al. J Cardiovasc Electrophysiol. 2009 Apr;20(4):395-400. doi: 10.1111/j.1540-8167.2008.01333.x. Epub 2008 Oct 27. J Cardiovasc Electrophysiol. 2009. PMID: 19017351

8

Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Levy PD, Nandyal D, Welch RD, Sun JL, Pieper K, Ghali JK, Fonarow GC, Gheorghiade M, O'Connor CM. Levy PD, et al. Am Heart J. 2010 Feb;159(2):222-230.e2. doi: 10.1016/j.ahj.2009.11.009. Am Heart J. 2010. PMID: 20152220

9

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.

Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV. Berger AK, et al. Am Heart J. 2007 Jun;153(6):1064-73. doi: 10.1016/j.ahj.2007.03.017. Am Heart J. 2007. PMID: 17540211

10

Failure of benefit and early hazard of bucindolol for Class IV heart failure.

Anderson JL, Krause-Steinrauf H, Goldman S, Clemson BS, Domanski MJ, Hager WD, Murray DR, Mann DL, Massie BM, McNamara DM, Oren R, Rogers WJ; Beta-Blocker Evaluation of Survival Trial (BEST) Investigators. Anderson JL, et al. J Card Fail. 2003 Aug;9(4):266-77. doi: 10.1054/jcaf.2003.42. J Card Fail. 2003. PMID: 13680547 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

282 results

Results by year